Publications by authors named "Pablo Winzer"

The apicomplexan parasite Neospora caninum is an important causative agent of congenital neosporosis, resulting in abortion, birth of weak offspring and neuromuscular disorders in cattle, sheep, and many other species. Among several compound classes that are currently being developed, two have been reported to limit the effects of congenital neosporosis: (i) bumped kinase inhibitors (BKIs) target calcium dependent protein kinase 1 (CDPK1), an enzyme that is encoded by an apicoplast-derived gene and found only in apicomplexans and plants. CDPK1 is essential for host cell invasion and egress; (ii) endochin-like quinolones (ELQs) are inhibitors of the cytochrome bc complex of the mitochondrial electron transport chain and thus inhibit oxidative phosphorylation.

View Article and Find Full Text PDF
Article Synopsis
  • - Bumped kinase inhibitors (BKIs), specifically BKI-1748, effectively inhibit the growth of apicomplexan parasites like Neospora caninum and Toxoplasma gondii, showing significant activity at low concentrations (ECs of 165 nM and 43 nM, respectively) when tested on fibroblast cells.
  • - Treatment with BKI-1748 led to the formation of multinucleated schizont-like complexes in infected cells, preventing the parasites from becoming infectious and egressing, and displayed no detrimental effects on zebrafish embryos or pregnant mice.
  • - In mouse models, BKI-1748 improved pup survival and reduced the transmission of N. caninum and T. gond
View Article and Find Full Text PDF

This is a review of the development of bumped-kinase inhibitors (BKIs) for the therapy of One Health parasitic apicomplexan diseases. Many apicomplexan infections are shared between humans and livestock, such as cryptosporidiosis and toxoplasmosis, as well as livestock only diseases such as neosporosis. We have demonstrated proof-of-concept for BKI therapy in livestock models of cryptosporidiosis (newborn calves infected with Cryptosporidium parvum), toxoplasmosis (pregnant sheep infected with Toxoplasma gondii), and neosporosis (pregnant sheep infected with Neospora caninum).

View Article and Find Full Text PDF

Exposure of tachyzoites to BKI-1294 results in the formation of long-lived multinucleated complexes (MNCs). However, treatment of BALB/c mice with BKI-1294 shortly after infection during pregnancy was safe and profoundly reduced pup mortality and vertical transmission. We hypothesized that the formation of MNCs could trigger immune responses that contribute to BKI efficacy .

View Article and Find Full Text PDF

Bumped kinase inhibitors (BKIs) are effective against a variety of apicomplexan parasites. Fifteen BKIs with promising in vitro efficacy against Neospora caninum tachyzoites, low cytotoxicity in mammalian cells, and no toxic effects in non-pregnant BALB/c mice were assessed in pregnant mice. Drugs were emulsified in corn oil and were applied by gavage for 5 days.

View Article and Find Full Text PDF

Background: the apicomplexan parasite causes important reproductive problems in farm animals, most notably in cattle. After infection via oocysts or tissue cysts, rapidly dividing tachyzoites infect various tissues and organs, and in immunocompetent hosts, they differentiate into slowly dividing bradyzoites, which form tissue cysts and constitute a resting stage persisting within infected tissues. Bumped kinase inhibitors (BKIs) of calcium dependent protein kinase 1 are promising drug candidates for the treatment of infections.

View Article and Find Full Text PDF

Background: Bumped kinase inhibitors (BKIs) are potential drugs for neosporosis treatment in farm animals. BKI-1294 exposure results in the formation of multinucleated complexes (MNCs), which remain viable in vitro under constant drug pressure. We investigated the formation of BKI-1294 induced MNCs, the re-emergence of viable tachyzoites following drug removal, and the localization of CDPK1, the molecular target of BKIs.

View Article and Find Full Text PDF

(1) Background: is a major cause of abortion in cattle and represents a veterinary health problem of great economic significance. In order to identify novel chemotherapeutic agents for the treatment of neosporosis, the Medicines for Malaria Venture (MMV) Malaria Box, a unique collection of anti-malarial compounds, were screened against tachyzoites, and the most efficient compounds were characterized in more detail. (2) Methods: A beta-galactosidase reporter strain grown in human foreskin fibroblasts was treated with 390 compounds from the MMV Malaria Box.

View Article and Find Full Text PDF

We report on the efficacy of selected endochin-like quinolones (ELQs) against tachyzoites grown in human foreskin fibroblasts (HFF), and in a pregnant BALB/c mouse model. Fourteen ELQs were screened against transgenic tachyzoites expressing β-galactosidase (Nc-βgal). Drugs were added concomitantly to infection and the values for 50% proliferation inhibition (IC) were determined after 3 days.

View Article and Find Full Text PDF

We report on the in vitro effects of the bumped kinase inhibitor 1294 (BKI-1294) in cultures of virulent Neospora caninum isolates Nc-Liverpool (Nc-Liv) and Nc-Spain7 and in two strains of Toxoplasma gondii (RH and ME49), all grown in human foreskin fibroblasts. In these parasites, BKI-1294 acted with 50% inhibitory concentrations (IC50s) ranging from 20 nM (T. gondii RH) to 360 nM (N.

View Article and Find Full Text PDF

The naphthoquinone buparvaquone is currently the only drug used against theileriosis. Here, the effects of buparvaquone were investigated in vitro and in an experimental mouse model for Neospora caninum infection. In 4-day proliferation assays, buparvaquone efficiently inhibited N.

View Article and Find Full Text PDF

From a panel of 34 artemisinin derivatives tested in vitro, artemisone, GC007 and GC012 were most efficacious at inhibiting Neospora caninum replication (IC50 values of 3-54nM), did not notably impair the invasiveness of tachyzoites and were non-toxic for human foreskin fibroblasts (HFFs). Transmission electron microscopy of drug-treated N. caninum-infected HFFs demonstrated severe alterations in the parasite cytoplasm, changes in the composition of the matrix of the parasitophorous vacuole (PV) and diminished integrity of the PV membrane.

View Article and Find Full Text PDF
Article Synopsis
  • Neospora caninum poses significant economic challenges due to veterinary diseases, yet few effective treatments exist, highlighting the need for new drug development strategies.
  • This study identifies NcCDPK1, a calcium-dependent protein kinase in N. caninum, as a promising target for new therapeutics, showing it can be inhibited by bumped kinase inhibitors (BKIs).
  • The study demonstrates that BKI compound 1294 effectively reduces N. caninum proliferation and lowers parasite levels in treated mice, suggesting its potential for treating neosporosis in livestock, although further research is needed on dosing and efficacy in cattle and dogs.*
View Article and Find Full Text PDF